Orexo expands further - broadens operations and recruits new employees
During 2004, Orexo has grown from 19 to 24 employees, and the company's portfolio of development projects has been expanded and advanced further. Concurrently, development of a new analytical laboratory has been initiated, in line with Orexo's ambition to reach long term profitability through sound and balanced growth, and to become a leading company in drug delivery.
"We are in an expansive phase with a number of projects in various stages of development and new projects under assessment. Our organization has been strengthened with additional expertise, to further development of these projects at an ambitious pace," says Zsolt Lavotha, CEO of Orexo. "At the same time we have built our own analytical laboratory, which is scheduled to become operational during first half of 2005. Due to this new construction, we can expand operations cost-efficiently while concurrently maintaining control of the development process. This will facilitate our ability to achieve our goal of delivering growth and profitability."
Other news from the department manufacturing
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.